|
|
| |
Abstract Submission Period |
|
|
|
|
| |
| Call for Abstracts has closed. |
| Abstract submission opens: |
Friday, December 15, 2017 |
| Abstract submission deadline: |
Thursday, March 1, 2018 at noon JST |
| |
Thursday, March 8, 2018 at noon JST |
| |
Thursday, March 14, 2018 at noon JST |
|
|
|
|
| |
|
|
|
|
| Free paper (Oral / Poster Presentation) |
|
|
|
| |
| |
JSMO2018 accepts abstracts for free paper.
Presentation style will be either Oral or Poster presentation. |
|
| Please select the abstract category from the list below. (The 1st & 2nd choices are required.) |
|
| |
| Abstract Category for Free Paper |
|
|
|
| |
| 1 |
- |
32 |
Biostatistics |
| 2 |
Pediatric malignancy |
33 |
Regulatory science |
| 3 |
Brain tumors |
34 |
Clinical trial support |
| 4 |
Head and neck cancer |
35 |
Molecular-targeted drug |
| 5 |
Breast cancer |
36 |
Cytotoxic drug |
| 6 |
Esophageal cancer |
37 |
Immunotherapy |
| 7 |
Gastric cancer |
38 |
Other anti-cancer drugs |
| 8 |
Colorectal cancer |
39 |
Pharmaceutical science |
| 9 |
Hepatoma / HCC |
40 |
Big data |
| 10 |
Biliary tract cancer / Pancreatic cancer |
41 |
Trials in progress (a) |
| 11 |
Lung cancer |
42 |
Molecular and genetic diagnosis |
| 12 |
Uterin cancer / Ovarian cancer |
43 |
Companion diagnostics |
| 13 |
Other gynecological cancer |
44 |
Diagnostic imaging |
| 14 |
Urologic cancer |
45 |
Other diagnostics |
| 15 |
Endocrine tumors / Thyroid cancer |
46 |
Supportive care |
| 16 |
Skin cancer |
47 |
Palliative medicine |
| 17 |
Bone and soft tissue tumors |
48 |
Regional medical network |
| 18 |
Lymphoma |
49 |
Team medical care |
| 19 |
Leukemia |
50 |
Rehabilitation |
| 20 |
Other hematological malignancies |
51 |
Outpatient chemotherapy |
| 21 |
Cancer of unknown primary |
52 |
- |
| 22 |
Neuroendocrine tumors |
53 |
- |
| 23 |
Hereditary neoplasm |
54 |
Oncology nursing |
| 24 |
Therapeutic radiology |
55 |
Oral care |
| 25 |
Basic research |
56 |
Patient advocacy / Cancer survivorship |
| 26 |
Immunology |
57 |
Adolescent and Young Adult Oncology |
| 27 |
Cancer epigenetics |
58 |
Geriatric Oncology |
| 28 |
Translational research |
59 |
Healthcare economics |
| 29 |
Innovative drug research & development |
60 |
Case reports |
| 30 |
Early clinical development |
61 |
Others |
| 31 |
Clinical pharmacology |
|
|
| |
| (a) |
Please note that if you select “Trials in Progress,” your abstract will NOT be included in the JSMO2018 USB abstract or any other available electronic program, such as “My schedule.” Your submitted abstracts will be printed and handed out to the participants at the room where you deliver your presentation. |
|
| * |
Abstract Encouragement Award |
| |
● |
Age limitation: The first author must be under the age 40 (as of July 21, 2018) |
| |
● |
Once you are nominated as a candidate, you will be requested to submit an electronic data for review in May, 2018. |
| |
● |
If you would like to be reviewed as a candidate, please check the box to be reviewed as the candidate for the Abstract Encouragement Award. |
|
| * |
All submitted abstracts will be reviewed by the Peer Review Committee and decided comprenensively based on the study contents, ethical aspects, and etc. You may choose the presentation style (oral or poster) when you submit an abstract. However, please understand that the congress president will make a final decision on the presentation style, presentation session, as well as acceptance/rejection. |
|
|
|
|
| |
JSMO2018 would like to deepen discussions based on the latest research results. We accept such abstracts as "Late-breaking abstracts".
If you are applying for Late-breaking abstracts, please select “Yes” for the question, “Are you applying for late-breaking abstracts?” and submit an outline and predicted results of your research as interim registration in the abstract text box.
Please complete the abstract submission with the latest research results by Friday, April 13, 2018.(You will be notified by the Secretariat to complete the abstract submission at the beginning of April.) |
|
| * |
Your abstract may not be included in the JSMO2018 USB Abstract if the complete abstract is submitted later than Friday, April 13. |
|
|
| |
Plenary Session (International Session) |
|
|
|
|
| |
| JSMO2018 will select the abstracts for “Plenary Sessions” from the submitted abstracts. |
|
|
|
|
| |
| Abstracts submitted by young researchers from outside Japan will be reviewed by the JSMO2018 committee members. Those selected presenters will be awarded partial travel grant for their outstanding works. |
|
| The award details are as follows: |
| * |
JPY50,000-100,000 of travel support to investigators from Asia. (depending on the quality of abstract) |
| * |
JPY150,000 of travel support to investigators from US or EU. |
| Note: |
To qualify for the travel award, you must be free of any commercial grant or support. |
|
|
|
|
| |
Publication in “Annals of Oncology” |
|
|
|
|
| |
Abstracts (oral/ poster) submitted in English for JSMO2018 Annual Meeting will be published in ESMO/JSMO Scientific Journal, supplement to “Annals of Oncology” (Oxford University Press).
If you wish to have your abstract published in “Annals of Oncology,” please select “Yes”. |
|
| * |
Terms to be published in Journal "Annals of Oncology" as to poster presentation: |
| |
| (1) |
Your abstract must be accepted for poster presentation. |
| (2) |
To be published in the Journal “Annals of Oncology,” the posting fee (5,000JPY) must be paid in addition to the Congress registration fee.
Secretariat will contact you once your abstract is accepted as poster presentation. |
|
|
|
|
| |
Disclosure of Conflict of Interest at the Japanese Society of
Medical Oncology 2018 Annual Meeting |
|
|
|
|
| |
| The first authors and directors (who are in charge of the studies, usually last author) must disclose applicable COI (Conflict of Interest) of your presentation at the meeting. Please inform the COI from January 1, 2015 to December 31, 2017. |
|
|
|
|
|
For oral presentation, please use the slide below as a template to disclose conflict of interest.
For poster presentation, please prepare and print out the slide, and put it at lower right of the poster panel. |
|
|
|
|
| Questions regarding COI disclosure |
|
|
|
| |
The Secretariat of the Japan Society of Medical Oncology |
| |
| E-mail: |
 |
|
|
|
|
|
|
|
|
|
| |
|
| |
We accept abstracts submitted online only through the submission system.
You may enter the submission page from “Abstract Submission” button at the bottom of this page. |
|
| (1) |
Author information and abstracts must be submitted in English. |
| (2) |
Abstract title must be up to 120 single-byte characters. |
| (3) |
Abstract text must be up to 2,000 single-byte characters. |
| (4) |
The maximum of 15 authors (first author & co-authors) can be registered. |
| (5) |
The maximum of 15 affiliations (including the affiliation of the first author) can be registered. |
| (6) |
Please structure your abstract as follows:
Background:
Methods:
Results:
Conclusion: |
| (7) |
Any chart or diagram cannot be included. |
| (8) |
Regarding the special characters, please refer here. |
| (9) |
In the registration page, you will be asked to enter the information such as
“application for Late-breaking abstracts”, “application for Travel Award”, “Publication in Annals of Oncology” as well as COI information. |
| |
| * |
It is recommended that you prepare your abstract text by Word/ text file in advance, and then copy it on the registration page. |
| * |
After completing the abstract submission, the abstract registration ID number and your password will be sent to the first author’s email address. The ID number and password will be required to confirm/modify/delete/add abstracts. Please be sure to enter the correct e-mail address. Please be sure to keep the ID number and password by yourself. The congress secretariat will NOT keep track of your information. |
|
|
|
|
|
|
| |
Confirmation / Modification / Deletion of Submitted Abstract &
Additional Submission |
|
|
|
|
| |
You can access to confirm/modify/delete/add abstracts during the abstract submission period.
The ID number and password will be required to enter the page (confirm/modify/delete/add abstracts). |
|
| |
Acceptance/Rejection Notification |
|
|
|
|
| |
Notification of acceptance/rejection will be sent to the first author by email by May, 2018. |
|
|
|
| |
|
| |
| |
Confirmation / Modification / Deletion of submitted abstract &
Additional submission |
|
|
|
|
| |
|
|
| |
Inquiries for Abstract Submission |
|
|
|
|
| |
Congress Secretariat
c/o Congress Corporation
1-9-17 Tenjin Chuo-ku, Fukuoka, Japan
Phone: +81-92-716-7116 Fax: +81-92-716-7143
E-mail: jsmo2018@congre.co.jp |
|
